new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Boehringer Ingelheim Vetmedica Gmbh patents

Recent patent applications related to Boehringer Ingelheim Vetmedica Gmbh. Boehringer Ingelheim Vetmedica Gmbh is listed as an Agent/Assignee. Note: Boehringer Ingelheim Vetmedica Gmbh may have other listings under different names/spellings. We're not affiliated with Boehringer Ingelheim Vetmedica Gmbh, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Boehringer Ingelheim Vetmedica Gmbh-related inventors




Date Boehringer Ingelheim Vetmedica Gmbh patents (updated weekly) - BOOKMARK this page
03/30/17Modular antigen transportation molecules and uses thereof in animals
03/23/17Ciclesonide for the treatment of airway disease in horses
03/16/17Treatment of metabolic disorders in equine animals
03/09/17Novel european prrsv strain
03/02/17Liquid pharmaceutical compositions comprising sglt-2 inhibitors
03/02/17Pestivirus vaccines for congenital tremors
02/09/17Highly concentrated stable meloxicam solutions
01/26/17Inhaler
01/19/17Inhaler
01/19/17Method for the preparation of a vaccinating agent
01/12/17Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
12/22/16Use of dihydroimidazolones for the treatment of dogs
12/22/16Connecting and container system
12/22/16Connecting and container system
12/15/16Treatment of metabolic disorders in canine animals
12/15/16H5 proteins of h5n1 influenza virus for use as a medicament
12/01/161-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal
11/03/16Prrs virus variant, european prrs virus cdna clone, and uses thereof
09/01/16Schmallenberg virus (sbv) vaccine, methods of production, and uses thereof
09/01/16Bivalent swine influenza virus vaccine
05/19/16Method of making a mycoplasma vaccine
05/05/16Method for producing a plurality of measurement regions on a chip, and chip with measurement regions
02/25/16Device for controlling fluid flows in lab-on-a-chip systems
02/18/16System for operating a system for the integrated and automated analysis of dna or protein
02/11/16Novel prrs virus inducing type i interferon in susceptible cells
02/11/16Method for operating a system for the integrated and automated analysis of dna or protein
02/04/16Nanoparticles, methods of preparation, and uses thereof
01/28/16Apparatus for the detection of liquids or substances from liquids
12/24/15Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
12/10/15Novel recombinant outer membrane proteins from brachyspira hyodysenteriae and uses thereof
11/05/15Ciclesonide for the treatment of airway disease in horses
10/01/15Treatment of metabolic disorders in equine animals
10/01/15Modular antigen transportation molecules and uses therof
09/24/15Treatment of epileptic disorders in feline animals
06/18/15Treatment of metabolic disorders in feline animals
06/18/15Cd2 deficient african swine fever virus as live attenuated or subsequently inactivated vaccine against african swine fever in mammals
06/04/15Pharmaceutical compositions of pimobendan
03/12/15Use of dihydroimidazolones for the treatment of dogs
03/05/15Pharmaceutical tablet formulation for the veterinary medical sector, production and use thereof
02/26/15Inhaler
02/26/15Inhaler
02/26/15Inhaler
02/19/15Highly concentrated stable meloxicam solutions for needleless injection
02/05/15Kit-in-parts for cleaning and treating ears of companion animals
01/22/15Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
12/18/14One dose vaccination against mycoplasma infections of pigs
12/11/14Pharmaceutical composition including pimobendan
12/11/14Oral suspension comprising telmisartan
11/13/14Water-soluble meloxicam granules
10/09/14Treatment of metabolic disorders in equine animals
09/25/14Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats
09/11/14Novel european prrsv strain
08/21/14H5 proteins of h5n1 influenza virus for use as a medicament
08/21/14Liquid preparation comprising pimobendan
08/14/14Kit-of-parts
08/14/14Taste masked pharmaceutical composition
08/14/141-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-axanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal
08/14/14Otic composition for companion animals
07/17/14Influenza h5 vaccines
07/03/14Immunogenic composition comprising mycoplasma antigens
07/03/14Method of making a mycoplasma vaccine
06/26/14Meloxicam for the treatment of respiratory diseases in pigs
06/26/14Pharmaceutical formulation comprising ciclesonide
06/26/14Ciclesonide for the treatment of airway disease in horses
06/19/14Funny current (if) inhibitors for use in a treating and preventing heart disease in canine
Patent Packs
06/05/14Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure
05/15/14Proton pump inhibitor for use in a treating dermatological diseases in canine
04/24/14Highly concentrated stable meloxicam solutions for needleless injection
03/06/14Highly concentrated stable meloxicam solutions for needleless injection
02/27/14Potassium containing preparation, process for the production thereof and use thereof
01/30/14Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
01/30/14Crystalline complex of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ss- d-glucopyranos-1-yl)-benzene, methods for its preparation and the use thereof for preparing medicaments
12/05/13Infectious schmallenberg virus from cloned cdnas and uses thereof
12/05/13Schmallenberg virus (sbv) vaccine, methods of production, and uses thereof
09/05/13One dose vaccination against mycoplasma infections of pigs
08/08/13Pde iii inhibitors for treatment of asymptomatic heart failure
08/01/13Water-soluble meloxicam granules
08/01/13Low concentration meloxicam tablets
07/25/13Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats
07/18/13Kit for the preparation of a vaccinating agent
Patent Packs
07/11/13Packaging assembly for pharmaceutical composition including pimobendan
07/11/13Highly concentrated stable meloxicam solutions
06/27/13Containers for compositions comprising meloxicam
04/04/13Taste masked pharmaceutical composition
02/14/13Vaccine comprising an attenuated pestivirus
02/14/13Inhibitors for treating and preventing heart failure in felines
02/07/13Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
01/31/13Novel prrs virus inducing type i interferon in susceptible cells
01/03/13Water-soluble meloxicam granules
08/23/12Commercial scale process for production of prrsv
08/23/12Novel european prrsv strain
08/09/12Infectious bovine viral diarrhea virus
08/02/12Gm-negative ehv-mutants without heterologous elements
07/26/12Attenuated pestiviruses
06/14/12Pharmaceutical composition comprising pimobendan
05/03/12Inhaler
04/19/12Pharmaceutical oral telmisartan solution
12/01/11Vaccine strains of brachyspira hyodysenteriae
11/10/11Hybridoma producing antibodies to lawsonia intracellularis
11/10/11Hybridoma producing antibodies to lawsonia intracellularis
11/10/11Hybridoma producing antibodies to lawsonia intracellularis
11/10/11Novel low concentration meloxicam tablets
10/13/11Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
10/06/11Process for production of vaccines
09/29/111-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal
09/08/11Use of meloxicam for the long term-treatment of kidney disorders in cats
08/18/11Hybridoma producing antibodies to lawsonia intracellularis
08/18/11Hybridoma producing antibodies to lawsonia intracellularis
08/18/11Hybridoma producing antibodies to lawsonia intracellularis
08/18/11Antibodies to lawsonia intracellularis
Social Network Patent Pack
08/18/11Hybridoma producing antibodies to lawsonia intracellularis
05/19/11Attenuated pestivirus
04/14/11Containers for compositions comprising meloxicam
02/10/11Hybridoma producing antibodies to lawsonia intracellularis
07/29/10Preparation for the treatment of equine laminitis
02/11/10Use of pde iii inhibitors for the treatment of asymptomatic (occult) heart failure
09/10/09Vaccine comprising an attenuated pestivirus
06/25/09Gm-negative ehv-mutants without heterologous elements
03/26/09Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Boehringer Ingelheim Vetmedica Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Boehringer Ingelheim Vetmedica Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';